Potential for peptides to replace antibodies in radiopharma, says WuXi AppTec exec
Focus is turning to the development of peptide analogues of antibody-derived radiotherapeutics, according to Dr Dave Madge.
Focus is turning to the development of peptide analogues of antibody-derived radiotherapeutics, according to Dr Dave Madge.
Takeda's research team will leverage Tempus' Lens platform, which provides access to anonymised patient data.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Phare Bio receives ARPA-H funds for AI drug discovery platform
AllazoHealth introduces AI offering to enhance medication initiation
AI boom set to revolutionise healthcare in Europe
Gilead and Genesis partner to create novel therapies using AI